Abstract
Dihydropyridine Ca channel blockers are widely prescribed for the treatment of hypertension and coronary artery diseases, but it remains unknown whether these agents protect against arrhythmias. We investigated whether cilnidipine, an N+L-type Ca channel blocker, reduces the incidences of ventricular premature beats (VPBs) and, if so, via what mechanisms. Japanese white rabbits underwent 30 min of ischemia and 48 h of reperfusion. Cilnidipine (0.5 or 1.0 μg/kg/min, i.v.) or saline (i.v.) was administered from 30 min before ischemia to 30 min after reperfusion. Electrocardiogram and blood pressure were monitored and the incidences of VPBs were measured. At 48 h after reperfusion, myocardial infarct was measured. Myocardial interstitial noradrenaline levels were determined before, during and after 30 min of ischemia with cilnidipine (0.5 and 1.0 μg/kg/min) or saline. The incidences of VPBs during ischemia and reperfusion were significantly attenuated in the cilnidipine 0.5 group (15.6±3.1 and 6.8±1.9 beats/30 min) and in the cilnidipine 1.0 group (10.4±4.9 and 3.5±1.0 beats/30 min) compared to the control group (27.2±4.5 and 24.2±3.1 beats/30 min), respectively. Myocardial interstitial noradrenaline levels were significantly reduced in the cilnidipine 0.5 and 1.0 groups compared to the control group during ischemia and reperfusion. The antiarrhythmic effect of cilnidipine may be related to the attenuation of cardiac sympathetic nerve activity. This finding may provide new insight into therapeutic strategies for hypertensive patients with ventricular arrhythmias.
Similar content being viewed by others
Article PDF
References
Maseri A, Chierchia S : Coronary spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis 1982; 25: 169–192.
Opie LH : Should calcium antagonist be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther 1993; 6: 19–24.
Ueyama H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N : Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurons. Br J Pharmacol 1997; 122: 37–42.
Hosono M, Fujii S, Hiruma T, et al: Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol 1995; 69: 127–134.
Daitoku K, Seya K, Motomura S : Cilnidipine suppresses DMPP-induced cardiac sympathetic nerve activation in canine blood-perfused papillary muscle. J Cardiovasc Pharmacol 1999; 34 ( Suppl 4): S81–S84.
Minami J, Ishimitsu T, Higashi T, Numabe A, Matsuoka H : Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertension. Hypertens Res 1998; 21: 215–219.
Yagi S, Goto S, Yamamoto T, Kurihara S, Katayama S : Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 2003; 26: 383–387.
Takami T, Shigemasa M : Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609–614.
Akiyama T, Yamazaki T, Ninomiya I : Differential regional responses of myocardial interstitial noradrenaline levels to coronary occlusion. Cardiovasc Res 1993; 27: 817–822.
Minatoguchi S, Uno Y, Kariya T, et al: Crosstalk among noradrenaline, adenosine and protein kinase C in the mechanisms of ischemic preconditioning. J Cradiovasc Pharmacol 2003; 41 ( Suppl 1): S39–S47.
Penny WJ : The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrythmias during ischaemia and reperfusion. Eur Heart J 1984; 5: 960–973.
Zhan CY, Tang F, Lee AY, Wong TM : Effects of reserpine treatment on arrythmogenesis during ischaemia and reperfusion in the isolated rat heart. Clin Exp Pharmacol Physiol 1989; 16: 591–596.
van Gilst WH, de Graeff PA, Kingma JH, de Langen CD, Wesseling H : Effects of diltiazem on reperfusion-induced arrythmias in vitro and in vivo. J Mol Cell Cardiol 1986; 18: 1255–1266.
Horwitz LD, Fennessey PV, Shikes RH, Kong Y : Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation 1994; 89: 1792–1801.
Reimer KA, Vander Heide RS, Richard VJ : Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993; 72: 13G–21G.
Norris RM : Beta blockers and infarct size. J Mol Cell Cardiol 1986; 19 ( Suppl 4): 99–103.
Toyooka T, Kamishiro T, Fumino H, Masaki T, Hosoda S : Rabbit hearts for the critical evaluation of drugs to reduce the size of experimentally produced acute myocardial infarction. Jpn Heart J 1984; 25: 623–632.
Tomiyama H, Kimura Y, Kuwabara Y, et al: Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine. Hypertens Res 2001; 24: 679–684.
Konda T, Takahara A, Maeda K, Dohmoto H, Yoshimoto R : Effects of a dual L/N- type Ca2+ channel blocker cilnidipine on neuronally mediated chronotropic response in anesthetized dogs. Eur J Pharmacol 2001; 413: 117–120.
Sakata K, Shirotani M, Yoshida H, et al: Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 1999; 33: 1447–1452.
Lombardi F, Verrier RL, Low B : Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J 1983; 105: 958–965.
Naito H, Furukawa Y, Chino D, Yamada C, Hashimoto K : Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrythmias. Eur J Pharmacol 2000; 388: 171–176.
Cinca J, Worner F, Carreno A, Bardaji A, Salas-Caudevilla A, Soler-Soler J : Reperfusion arrythmias after chronic regional denervation of the ischaemic myocardium in pigs. Cardiovasc Res 1992; 26: 962–967.
Kirchengast M, Hergenroder S : Reperfusion arrythmias in closed-chest rats: the effect of myocardial noradrenaline depletion and Ca2+-antagonism. Clin Exp Pharmacol Physiol 1991; 18: 217–221.
Yamaguchi N, Kimura T, Lamontagne D, de Champlai J, Nadeau R : Occlusion time dependency of regional noradrenaline release and cardiac arrythmias during reperfusion of acutely ischaemic heart in the dog in vivo. Cardiovasc Res 1990; 24: 688–696.
Thandroyen FT, McCarthy J, Burton KP, Opie LH : Ryanodine and caffeine prevent ventricular arrythmias during acute myocardial ischemia and reperfusion in rat heart. Circ Res 1988; 62: 306–314.
Kihara Y, Morgan JP : Intracellular calcium and ventricular fibrillation: studies in the aequorin-loaded isovolumic ferrer heart. Circ Res 1991; 68: 1378–1389.
Brooks WW, Conrad CH, Morgan JP : Reperfusion induced arrythmias following ischaemia in intact rat heart: role of intracellular calcium. Cardiovasc Res 1995; 29: 536–542.
Hirayama Y, Saitoh H, Atarashi H, Hayakawa H : Electrical and mechanical alternans in canine myocardium in vivo: dependence on intracellular calcium cycling. Circulation 1993; 88: 2894–2902.
Woodward B, Zakaria MNM : Effect of some free radical scavengers on reperfusion induced arrhythmia in the isolated rat heart. J Mol Cell Cardiol 1985; 17: 485–493.
Bernier M, Hearse DJ, Manning AS : Repefusion-induced arrhythmia and oxygen-derived free radicals: studies with “anti-free radical” interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986; 58: 331–340.
Long W, Zhao Y, Zhang L, Longo LD : Role of Ca2+ channels in NE-induced increase in [Ca2+] i and tension in fetal and adult cerebral arteries. Am J Physiol 1999; 277: R286–R294.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagai, H., Minatoguchi, S., Chen, XH. et al. Cilnidipine, an N+L-Type Dihydropyridine Ca Channel Blocker, Suppresses the Occurrence of Ischemia/Reperfusion Arrhythmia in a Rabbit Model of Myocardial Infarction. Hypertens Res 28, 361–368 (2005). https://doi.org/10.1291/hypres.28.361
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.28.361
Keywords
This article is cited by
-
Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats
Hypertension Research (2015)
-
Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel
Hypertension Research (2012)
-
The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet
Heart and Vessels (2010)
